Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
  • A61F2/01—Filters implantable into blood vessels
  • A61F2/0105—Open ended, i.e. legs gathered only at one side
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
  • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
  • A61F2/01—Filters implantable into blood vessels
  • A61F2002/016—Filters implantable into blood vessels made from wire-like elements
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
  • A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
  • A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
  • A61F2230/0004—Rounded shapes, e.g. with rounded corners
  • A61F2230/0006—Rounded shapes, e.g. with rounded corners circular
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
  • A61F2230/0063—Three-dimensional shapes
  • A61F2230/0073—Quadric-shaped
  • A61F2230/0078—Quadric-shaped hyperboloidal
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
  • A61F2230/0063—Three-dimensional shapes
  • A61F2230/0091—Three-dimensional shapes helically-coiled or spirally-coiled, i.e. having a 2-D spiral cross-section
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
  • A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
  • A61F2250/003—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in adsorbability or resorbability, i.e. in adsorption or resorption time
  • A61F2250/0031—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in adsorbability or resorbability, i.e. in adsorption or resorption time made from both resorbable and non-resorbable prosthetic parts, e.g. adjacent parts

Definitions

• the present disclosure relates to novel enhanced surgical tools.
• the present disclosure describes apparatus useful for vascular surgical and interventional radiological procedures having needs for improved trapping surfaces.
• the present inventors have overcome longstanding issues in preventing recurrent pulmonary embolism, among other things, by percutaneous placement of an improved biodegradable filter in the vena cava.
• This enhanced treatment modality addresses pulmonary thromboembolism when anticoagulants are contraindicated, treats thromboembolic disease, addresses massive pulmonary embolism and chronic, recurrent embolisms better than existing devices. Safer devices are sorely needed, along with those that are effective.
• a biodegradable vascular filter system which comprises, in combination, a self- expanding apparatus which undergoes a phase change enabling it to move from a first position to a second position, operatively connected with a plurality of polymeric string-like members, which members expand from a slackened to a tensioned state in conjunction with the phase change of the associated apparatus, wherein the system when in at least one vessel and/or lumen is effective for trapping matter traveling therethrough.
• a middle position whereby the polymeric string-like members are in a slackened, or atensional state is often appropriate depending on the indication.
• a process for mitigating insult and injury by thrombus comprising, in combination, providing a vascular filter device further comprising a nitinol skeleton operatively linked to a biodegradable polymer, implanting the vascular filter device at a desired location within the vessel and leaving the vascular filter device in situ.
• a biodegradable vascular filter system which comprises, in combination, apparatus effective for being lodged within a vessel and a plurality of polymeric string-like members, which members may be disposed in at least one configuration from a slackened to a tensioned state when implanted within the vessel, including at least a conical and a frusto-conical configuration, wherein the system when implanted in at least one of a vessel and a body lumen and is effective for trapping thrombi traveling therethrough.
• novel enhanced products and processes for trapping emboli utilize self-expanding skeletons and biodegradable polymer systems, for example stent-like Nitinol® elements and PLGA, to address longstanding issues related to thrombus capture without deleterious impacts on the vasculature or other negative artifacts of the procedure by at least partial post- use dissolution in situ.
• Figure 1 is a schematic showing a biodegradable filter according to embodiments of the present disclosure
• Figure 2 is a schematic top view showing a biodegradable filter according to embodiments of the present disclosure
• Figure 3 is a schematic partial perspective view of a biodegradable filter according to embodiment of the present disclosure
• Figure 3A is another schematic showing a deployment in which a first a-tensional state is depicted
• Figure 3B is an additional schematic showing a deployment in which a second a-tensional state is depicted;
• Figure 4 is a schematic side view of a biodegradable filter according to embodiments of the present disclosure.
• Figure 5 is a schematic side view according to embodiments of the present disclosure.
• Figure 6 is a partial plan view of a biodegradable filter according to embodiments of the present disclosure.
• Figure 7 is a side view of a biodegradable filter according to embodiments of the present disclosure
• Figure 8 is a side view of a biodegradable filter.
• the present inventors have discovered a novel enhanced process and products to mitigate thrombic insult, injury and related and attendant harms.
• a shape memory alloy, or plastic for example Nitinol®
• biodegradable polymer systems an improved surgical filter effective to arrest transmissions of thrombus is disclosed.
• Processes using various embodiments are also taught, where the polymer systems are absorbed, or degrade while the skeleton grows into the vessel.
• biodegradable polymer system includes any related biocompatible set of moieties approved, or to be approved, for use in animals.
• poly(lactic-co-glycolic) acid hereafter “PLGA”
• FDA U.S. Food and Drug Administration
• delivery systems are conventional, and used by all of the major cardiovascular disease companies, which must be given consideration in the design and execution of such medical devices.
• the trend in these devices is procurement of larger and more effective trapping surfaces and smaller and less invasive insertion systems.
• Prominent examples of the other devices in these fields include the LP brand of filter from B. Braun, the Gunther TulipTM brand of Vena Cava filter, and the Cordis Optease brand of permanent vena cava filter, in addition to the Recovery brand of filter system offered by Bard Peripheral Vascular, a division of CR. Bard Incorporated. Unacceptably high records of adverse events are associated with all of these devices.
• PLGA may be synthesized by the co-polymerization of glycolide and lactide.
• the present inventors have searched predicate devices and approaches but are unaware of other usages of PLGA or other such biodegradable polymer such as those taught according to the present disclosure.
• those skilled in the art readily understand that any number of materials with an in situ history shall suffice for the purposes of the present invention.
• vascular filters have commonly been adapted or used in a other lumens as needed. See, for example Fig. 5 through Fig. 8.
• Filter occlusion from trapped emboli, often results in adverse events ranging from renal failure, the need for heightened thrombolytic therapy, to death of the subject patients.
• Metal fatigue and fracture, poor flow characteristics and areas of stagnation also generate significant issues.
• Fixation hooks associated with known devices, and the high radial force associated with the deployment of known systems have also added vasculature insult and injury to the list.
• novel enhanced biodegradable filter is generally and schematically illustrated as device 101 struts 111 , as deployed leverage off of the benefits of Nitinol®, or "spring steel" which moves from a first (compacted) position to a second (expanded) condition upon release within an environment having a higher temperature - such as the desired lumen of a vessel.
• PLGA matrix 113 provides for a trapping mechanism when tensioned by the expansion of Nitinol® struts 11 1 as the 'spring steel' moves from a first to a second position.
• FIG. 2 it is shown how expanded struts 111 of device 101 can render PLGA (or any other biodegradable polymer system, as set forth and discussed above and claimed below) matrix 113 effective to trap emboli, without the constraint of concomitant flow restriction.
• Deployment of device 101 does not cause vessel damage through high radial force, nor do damages by ripping into the vessel wall. Rather Nitinol® struts 111 merge gently with vessel walls, growing into the neointima of the vessels.
• a stent-like embodiment of device 100 features Nitinol® hoops 117, whose memory allows them to be situated within a delivery catheter and through minimally invasive techniques, delivered to an appropriate site.
• Nitinol® hoops 117 whose memory allows them to be situated within a delivery catheter and through minimally invasive techniques, delivered to an appropriate site.
• PLGA or other biodegradable bioabsorbable material may be used for hoops 117.
• Figures 3A and 3B show how different degrees of tension may be employed in various different states, depending on where the instant system is used. Those skilled in the art readily understand where and how this best works, in terms of the human vasculature.
• shape-memory alloys whose function as is well know to those skilled in the art in accordance with the SMART®-type of self expanding stent (Cordis Endovascular, Johnson & Johnson), to render device 101 effective to be delivered by known systems of catheters, and to be placed at an appropriate juncture in a vessel without damaging the same.
• placement in any known vessel by a femoral insertion of an introducer and guidewire system available from Medtronic® AVE, Guidant®, Edward LifeSciences® LLC or Cook Endovascular as approved by the U.S. FDA), is conventional.
• stent-like device 101 with for example PLGA web 113, are significant in comparison to known teachings. For example, as opposed to leaving the filter in the patient, or attempting to retrieve the same by dragging it out, each of which does more harm than good - the instant disclosure teaches leaving the device in, the PLGA to dissolve over time, while the remaining assembly is endothelialized and encased in the wall of the vessel.
• This biodegradable filter 201 once again is comprised of Nitinol® struts 211, which are shown in a first (compacted) condition within catheter/delivery system 222. Once more, "spring-steel” may be chilled, cooled or otherwise restrained to maintain this first state. Nitinol® 211 undergoes a phase change from austenite to martenite upon a correct temperature change and the "memory" it has allows the health-care provider to size it appropriately for the desired vessel.
• PLGA is an effective polymer system, and those skilled in the art will understand that others may be used as well.
• Figures 5-8 demonstrate a second or expanded state of Nitinol® struts, respectively proximate 311 and distal 312 (411 , 511 ) as used to filter emboli in different vessels.
• Figure 5 for example may be used for pregnant patients with thromboembolism. In such a disease state, extensive iliofemoral deep vein thrombosis with thrombolytic therapy or surgical thrombus- generating procedures are a major area of concern. The devices in the field are designed to trap emboli during these procedures, but generally add more risk factors than they prevent. The instant disclosure overcomes these issues and allows surgeons and interventionalists an option.
• Figures 6-8 show customized versions which may be used as temporary filters.
• the present invention allows medical practitioners to address trapping issues at various locations in the vasculature, as known to artisans.
• Figure 7 and Figure 8 use Nitinol® stent-like members 411 ,
• Anchor 538 may also be used for smaller vessels or specialized approach where lumens are challenging to access or require alternate positioning means. Such usages are within the ambition of surgeons or interventional radiologists of skill in the art, and so further discussion is omitted at this time.

Landscapes

• Health & Medical Sciences (AREA)
• Cardiology (AREA)
• Oral & Maxillofacial Surgery (AREA)
• Transplantation (AREA)
• Engineering & Computer Science (AREA)
• Biomedical Technology (AREA)
• Heart & Thoracic Surgery (AREA)
• Vascular Medicine (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Surgical Instruments (AREA)
• Materials For Medical Uses (AREA)
• Prostheses (AREA)

Priority Applications (3)

Applications Claiming Priority (2)

Publications (1)

Family

ID=37807856

Family Applications (1)

Country Status (5)

Cited By (1)

Families Citing this family (23)

Citations (6)

Family Cites Families (65)

• 2005
  • 2005-11-17 US US11/281,128 patent/US20070112372A1/en not_active Abandoned
• 2006
  • 2006-11-16 WO PCT/US2006/044482 patent/WO2007061743A1/en not_active Ceased
  • 2006-11-16 EP EP06837766.2A patent/EP1948071B1/en not_active Not-in-force
  • 2006-11-16 JP JP2008541339A patent/JP5688703B2/ja not_active Expired - Fee Related
  • 2006-11-16 ES ES06837766.2T patent/ES2555311T3/es active Active
• 2013
  • 2013-05-21 JP JP2013107529A patent/JP5863051B2/ja not_active Expired - Fee Related
• 2016
  • 2016-09-29 US US15/279,742 patent/US20170239032A1/en not_active Abandoned

Patent Citations (11)

Also Published As

Similar Documents

Legal Events